Complexity in bispecific and fusion antibody design
Stringent regulatory standards for IND submissions
Ensuring scalability and reproducibility of genetic tools
High costs and extended timelines in preclinical development
Complex bispecific and fusion constructs.
Linker oligos and advanced modifications for ADC research.
Optimized constructs for CHO and HEK293 systems.
GMP-compliant production standards
Strong experience in complex construct design
End-to-end service from research-grade to GMP-ready materials
Trusted partner for global biotech and pharma customers
Stay updated with the latest industry news and expert insights.
Subscribe now to receive:
● Industry updates
● Exclusive expert insights and analysis
Enter your email to stay ahead!
